Home » Topics » BioWorld Science

BioWorld Science
RSS

TAXIS Pharmaceuticals divulges bacterial efflux pump inhibitors

Dec. 17, 2021

Factor V/Va-targeting MAb GB-5 promotes thrombus formation in vivo for treating bleeding disorders

Dec. 17, 2021

Targeting S100A7/RAGE signaling pathway inhibits breast tumorigenesis

Dec. 17, 2021

ACE2-IgG4-Fc fusion protein neutralizes SARS-CoV-2, including several variants, at pM concentration

Dec. 17, 2021

The GABA aminotransferase inhibitor OV-329 shows anticonvulsant effects in two rat seizure models

Dec. 17, 2021

First preclinical data presented for chimeric fusion protein AT-03 in amyloidosis

Dec. 17, 2021

SAB-185 neutralizes SARS-CoV-2 Omicron variant in in vitro pseudovirus model

Dec. 16, 2021

GALE is a biomarker of inherited thrombocytopenia

Dec. 16, 2021

BridGene and Peter MacCallum Cancer Centre enter research collaboration for ovarian cancer

Dec. 16, 2021

Discovery of long-acting entecavir prodrugs

Dec. 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...